111 Inc banner

Intrinsic Value

The intrinsic value of 111 Inc (8110) under the Base Case is 5.28 EUR per share. Compared with the current market price of 4.16 EUR, the stock appears Undervalued by 21% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

Intrinsic Value
€5.28
Undervaluation 21%
Intrinsic Value
Price €4.16

111 Inc is more expensive than usual. Still undervalued, but at its most expensive valuation in the past 3 years.

Monitor 111 Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €4.23
Get notified when the price drops into your buy zone
Intrinsic Value €5.28
Margin of Safety 20% €4.23
Current Price €4.16
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 111 Inc

Fundamental Analysis

What 111 Does

Retail Consumer Staples

111 Inc is a China-based healthcare company that connects drug makers, pharmacies, doctors, and patients through an online platform. It sells prescription medicines, over-the-counter drugs, and other health products, and it also helps people find and buy care through digital channels. Its main customers are consumers, pharmacies, and healthcare partners that need a faster way to source medicines and serve patients.

Headquarters
China CN
Employees
1 238
IPO date
Sep 12, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
111 Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

YI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 111 Inc stock?

The intrinsic value for 111 Inc (8110) under the Base Case is 5.28 EUR.

Is 111 Inc stock undervalued or overvalued?

Compared with the current market price of 4.16 EUR, the stock appears Undervalued by 21% .

Back to Top